- Study Description
-
Important Links and Information
Through clinical trials focused on molecularly guided therapy in pediatric cancers (NCT01355679, NCT01802567, NCT02162732), the Beat Childhood Cancer Consortium performed paired tumor/normal whole exome sequencing and/or tumor mRNA sequencing for 202 pediatric or adolescent young adult patients with rare, relapsed and refractory cancers (including neuroblastoma, Ewing sarcoma, osteosarcoma, rhabdomyosarcoma, ependymoma, glioma, and other rare solid tumors). A subset of these patients had multiple biopsies sequenced, including longitudinal profiling.
- Authorized Access
- Publicly Available Data
Link to other NCBI resources related to this study
-
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Authorized Data Access Requests
-
- Study Attribution
-
-
Principal Investigator
-
Jeffrey M. Trent.
Translational Genomics Research Institute (TGen), Phoenix, Arizona, USA.
-
Giselle L. Saulnier Sholler.
Levine Children's Hospital, Charlotte, North Carolina, USA.